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Summary The incidence of in situ breast cancer in the USA has increased rapidly in recent years, even among
young women. A population-based case-control study of 1616 breast cancer cases aged under 45 in the USA
was used to examine risk factors for in situ, local and regional/distant tumours. Almost 60% of in situ tumours
were detected by routine mammograms compared with 18% of local tumours and 8% of regional/distant
tumours. After adjustment for screening history and established risk factors, family history of breast cancer in
a first-degree relative and African-American race were associated with an increased risk of all stages of breast
cancer. The associations with nulliparity, a previous breast biopsy and body mass index were significantly
stronger for in situ tumours than for local or regional/distant disease. Alcohol consumption was associated with
an increasing trend in risk of regional/distant tumours but not of earlier stage tumours, indicating that alcohol
may be involved in late-stage events. Analyses by histological type of in situ tumours suggested that both ductal
and lobular carcinoma in situ were associated with most established breast cancer risk factors, and the
magnitude of association tended to be greater for the ductal form.
Keywords: breast cancer; carcinoma in situ; invasive breast cancer; epidemiology; premenopausal
The incidence of in situ carcinoma of the breast among
women in the USA has increased about 4-fold since 1973, in
contrast to only a slight increase in invasive breast cancer
incidence (Hankey et al., 1993). As a result, in situ tumours
accounted for about 12% of diagnosed breast cancers in
1990, compared with less than 5% in the period 1973-80.
The increased use of mammographic screening during these
years explained most of the increase among older women
(Lantz et al., 1991; Liff et al., 1991; Feuer and Wun, 1992). It
is less likely that the 3-fold increase in incidence of in situ
tumours that occurred among women aged less than 50 is
caused by screening, owing to the low prevalence of screening
among women in this age group (White et al., 1990; Lantz et
al., 1991).
There are two main types of in situ breast carcinoma, the
ductal and lobular forms, and their relationship with invasive
breast cancer is not clearly understood. Ductal carcinoma in
situ (DCIS) can be detected by mammography and is thought
to represent a transitional stage in the development of an
invasive tumour, with over 25-50% of tumours progressing
to invasion, usually in the same breast (Ponten et al., 1990;
Bodian, 1993). In contrast, lobular carcinoma in situ is not
clinically detectable by mammography and is usually an
incidental finding during a biopsy. LCIS is probably a
marker of high risk of subsequent invasive cancer in either
breast, rather than a transitional stage in invasive malignancy
(Ponten et al., 1990) and the risk of developing invasive
breast cancer following biopsy-treated LCIS is approximately
8% in both ipsilateral and contralateral breasts (Bodian,
1993). Evidence of the association between in situ and
invasive disease (i.e. local or regional/distant tumours) was
strengthened recently by research showing that the tumour-
suppressor gene on chromosome 11 is mutated or missing in
both invasive and in situ breast cancer (Holzman, 1995). The
rapid increase in incidence of in situ tumours has prompted
recent epidemiological studies to include in situ tumours as
well as invasive tumours in analyses, but few studies have
examined differences in risk factors by stage of disease. A
follow-up study carried out within a nationwide screening
programme [the Breast Cancer Demonstration Detection
Project (BCDDP), Brinton et al., 1983] found a number of
shared risk factors for in situ and invasive tumours, including
a family history of breast cancer, previous breast biopsy and
late age at first livebirth. However, this study was limited by
lack of information on complete screening history. Results
from another study (Dubin et al., 1984) showed no evidence
that in situ tumours were associated with family history of
breast cancer or a previous breast biopsy, although there was
a significant association with a breast lump or cyst, and for
African-American women compared with white women.
The present case-control study is the largest study of
women aged under 45 to compare risk factors for in situ,
local and regional/distant breast cancer. In addition, risk
factors for histological types of in situ tumours have been
examined. The role of screening bias is especially important
in studies of non-invasive tumours, as screening procedures
such as frequent mammograms are likely to detect tumours at
an early stage. In this study, detailed screening information
was collected at the time of interview for cases and controls,
allowing the effect of screening on stage at diagnosis to be
evaluated.
Materials and methods
This population-based case-control study was conducted in
three different geographic areas of the USA covered by
cancer registries -Atlanta, Seattle/Puget Sound and five
counties in central New Jersey. Study details have been
published elsewhere (Brinton et al., 1995). Briefly, the present
analyses consist of women aged 20-44 years who were newly
diagnosed with breast cancer during the period 1 May 1990
to 31 December 1992. Cases were identified through rapid
ascertainment systems, and histological information on stage
at diagnosis was obtained from the Cancer Surveillance
Epidemiology and End Results (SEER) programme for cases
from Atlanta and Seattle, and from hospital records for cases
from New Jersey. Controls were chosen through random
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digit dialling and were frequency matched by geographic area
and age to the expected distribution of cases. A 90.5%
response rate to the telephone screening call was obtained
from 16 254 telephone numbers.
Structured in-person interviews were carried out, and
complete interviews were obtained from 1668 of the 1939
eligible cases (86.0%) and 1505 of the 1912 eligible controls
(78.7%). In order for the cases to be comparable with the
controls, the 21 cases without residential telephones were
excluded from the analyses. The interview, which lasted a
median of 71 min, included detailed information about
demographic factors, reproductive and menstrual history,
contraceptive behaviour, use of exogenous hormones, medical
and screening history, and smoking and alcohol consump-
tion. Cases were also asked about the method of detection of
breast cancer. All information on risk factors was truncated
at the date of diagnosis for cases or the date of completion of
the telephone screening call for controls (the reference date).
In addition, anthropometric measurements including height
and weight were taken following the interview, and obesity
was assessed using Quetelet's body mass index (kg m-2).
Alcohol intake was defined as the lifetime average number of
drinks consumed up to two years before reference date (a
drink was defined as 12 oz. beer, 1.5 oz. liquor or 4 oz. wine).
Screening history was ascertained by a series of questions
pertaining to the 5 year period up to 1 year before reference
date. Women were also asked about their frequency during
this period of routine mammograms, breast examinations by
a doctor or other trained professional, breast self-examina-
tions or Pap smears.
The stage of disease at diagnosis was categorised for each
case using the Summary Staging Guide published by the
SEER programme (1983). Tumours were defined as in situ if
they were non-infiltrating or intraductal without infiltration.
Local stage tumours were infiltrating but confined to breast
tissue, including the nipple and/or areola, and tumours were
classified as regional/distant if there was direct extension to
subcutaneous tissue, skin or muscles, invasion of the chest
wall, ribs or lymph nodes or metastasis. Information on
histology was available for all but four in situ cases, and risk
factors for different histological types of in situ tumours were
examined. The International Classification of Diseases for
Oncology (ICD-0) codes (Percy et al., 1990) were used to
classify tumours as follows: intraductal or ductal carcinoma
in situ (85002, 85012, 85032, 85042), lobular carcinoma in situ
(85202), both infiltrating ductal and lobular carcinoma in situ
(85222), intraepithelial carcinoma in situ (80102) and cribri-
form carcinoma in situ (82012).
Relative risks (RRs) and 95% confidence intervals (CIs) were
calculated by nominal polychotomous logistic regression
(Dubin and Pasternack, 1986) using the computer package
BMDP (Dixon, 1990). This is an extension of dichotomous
logistic regression, and is applicable to case-control studies
involving more than two disease categories. The numbers of
events in each disease stage are compared simultaneously
with the control group, under the assumption that events
follow a multinomial distribution across the categories. The
following risk factors were adjusted for in all analyses of
RRs: age at diagnosis, race, study site, family history of
breast cancer in a first degree relative, previous breast biopsy,
number of full-term births, age at first full-term birth, age at
menarche, years of oral contraceptive use, body mass index
and the number of mammograms in the 5 year period prior
to 1 year before reference date. Heterogeneity between risk
estimates for different disease stages was examined by a
significance test for a difference in the log relative risks (Begg
and Zhang, 1994). Tests for trend were carried out by
categorising the exposure variable and treating the scored
variable as continuous, after eliminating unknown values.
The associations between stage at diagnosis and screening
history, and between screening history and risk factors were
evaluated by the chi-square test for a difference in
proportions (Armitage and Berry, 1987). The association
between two screening methods was measured by the kappa
statistic (Fleiss 1973).
Results
A total of 1647 breast cancer cases were eligible for analysis.
Information on stage was not available for 31 cases. Of the
remaining 1616 cases, 228 (14%) were diagnosed with
carcinoma in situ, 784 (49%) with local tumours, and 604
(37%) with regional or distant disease. The stage distribution
was similar to that seen among women aged under 50 years
registered by SEER in 1990 (15% in situ, 46% local, 36%
regional/distant and 2% unknown; Hankey et al., 1993).
Women diagnosed with in situ tumours tended to be slightly
older (mean age at diagnosis 39.6 years) than women with
local or regional/distant tumours (mean ages at diagnosis
38.9 and 38.8 years respectively). The mean age of the control
group at the telephone screening call was 38.3 years.
The method of detection of breast cancer, as reported by
the patients, varied with stage of disease and age at diagnosis
as shown in Table I. Routine mammograms were the most
common method of detection of in situ tumours, accounting
Table I Method of detection of breast cancer by age and stage at diagnosis
Stage at diagnosisa
In situ Local Regional/distant Total
Method of (n=214) (n= 784) (n=602) (n= 1600)
detection n % n % n % n %
Age < 35
Mammogram 8 30 1 1 3 2 12 4
Self/partnerb 8 30 112 85 88 88 208 80
Physical examination 6 22 12 10 5 5 23 9
Otherc 5 19 6 5 5 5 16 6
Age 35-39
Mammogram 35 65 36 16 12 6 83 18
Self/partnerb 15 28 171 74 150 80 336 71
Physical examination 3 6 20 9 15 8 38 8
Otherc 1 2 5 2 10 5 16 3
Age 40-44
Mammogram 81 61 105 25 32 10 218 25
Self/partnerb 32 24 256 61 233 74 521 60
Physical examination 9 7 37 9 25 8 71 8
Otherc 11 8 23 5 24 8 58 7
aData on methods of detection were not available for 14 in situ cases and two regional/distant cases. bIncludes breast self-examination and
accidental discovery by the patient or her partner. cIncludes pain, infection, mastitis, swelling, dimpling and nipple discharge or bleeding.In situ and invasive breast cancer
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for over 60% of in situ tumours in women aged 35 or over
and 30% ofthose in younger women. The proportion oflocal
and regional/distant tumours detected by routine mammo-
grams increased with age at diagnosis, but at all ages these
tumours were most frequently detected by the patient or her
partner. Among women diagnosed aged less than 35, over
85% of local or regional/distant tumours were self-detected.
Less than 10% of all tumours were detected during a physical
examination by a doctor, although among young women,
22% of in situ tumours were detected in this way.
Cancer screening methods used by cases and controls in
the 5 year period more than 1 year before the reference date
are shown in Table II. Each combination of screening
methods was significantly correlated with each other as
measured by the kappa statistic (P < 0.001). For each pair of
screening methods, about 60% of women had agreement of
use (i.e. either used both methods or did not use both
methods). The proportion of women who had had a
mammogram varied greatly by stage of tumour at diagnosis
(P<0.001). Among the women diagnosed with in situ
tumours, 66% had had a mammogram in the 5 year period
more than a year before reference date and 27% had three or
more. In contrast, less than half of the women diagnosed
with regional/distant tumours had had a mammogram in this
period. Over 70% of women reported practicing breast self-
examination in this 5 year period and there was no evidence
that the proportion differed by tumour type (P=0.45). The
proportion of women who reported having had a physical
breast examination or a Pap smear in this period differed
significantly by tumour stage. Both examinations were more
common among women subsequently diagnosed with in situ
or local tumours than among women diagnosed with
regional/distant tumours or controls.
Table III shows the frequency ofmammographic screening
in the 5 year period more than a year before reference date,
by selected breast cancer risk factors. Overall, 14% of women
had undergone at least three mammograms in this period. Of
women with a family history of breast cancer in a first-degree
relative, 29% had three or more mammograms in this period,
compared with 12% of women without a family history.
Similarly, 37% of women with a breast biopsy had had three
or more mammograms compared with 12% of women
without a breast biopsy. The differences between these
proportions were statistically significant (P <0.001). White
women were more likely to have undergone frequent
screening than African-American women (15% vs 9%;
P <0.001), as were women with at least some college
education compared with those with no college education
(15% vs 12%; P=0.03).
Table IV shows relative risks for each stage of cancer,
associated with a family history of breast cancer, a previous
breast biopsy and race. Breast cancer in a first-degree relative
was associated with more than a 2-fold risk for each stage of
cancer, and there was no evidence of heterogeneity between
the RRs for any two stages at diagnosis (P>0.57). The
magnitude of risk tended to be slightly greater among women
with only an affected mother than among women with only
an affected sister, although the numbers of women with an
affected sister were small and confidence intervals were wide.
Women with both a mother and sister affected were at the
greatest risk for each stage of disease, although again these
results are based on very small numbers.
A previous breast biopsy was associated with a significant
2-fold relative risk for in situ tumours (RR= 1.99) and
smaller, non-significant, increased risks for local and
regional/distant tumours (RRL= 1.23, RRR/D=1.28). The
test for heterogeneity showed that the magnitude of risk
was significantly greater for in situ tumours than for local
tumours (P=0.04), and to a lesser extent, regional/distant
tumours (P=0.08). Further analyses showed that the
increased risk for in situ tumours was confined to women
aged 25 or older at first biopsy (RR< 25ys=0.64, RR25
34yrs=2.44, RR35 44yrs =2.43).
There was an increased risk for African-American women
compared with white women for all stages of disease. The
risk was greater for in situ tumours (RR= 1.84), than for
local (RR= 1.25) or regional/distant tumours (RR= 1.38),
but the differences in risk by stage were not statistically
significant (Pk0.12). No effect was seen for other non-white
races, although results were based on small numbers.
Table III Frequency ofmammographic screening by selected breast
cancer risk factors in cases and controls in the 5 year period prior to
1 year before reference datea
Number ofmammograms
Riskfactor None 1-2 3+
Total 1566 (50%) 1113 (36%) 436 (14%)
First-degreee
family history
Yes 92 (28%) 139 (43%) 93 (29%)
No 1460 (53%) 964 (35%) 338 (12%)
Previous breast
biopsy
Yes 44 (18%) 114 (45%) 93 (37%)
No 1522 (53%) 999 (35%) 343 (12%)
Race
White 1163 (47%) 917 (37%) 380 (15%)
African- 275 (59%) 145 (31%) 44 (9%)
American
Other 128 (67%) 51 (27%) 12 (6%)
Educated to
college level
Yes 1005 (49%) 754 (37%) 305 (15%)
No 561 (53%) 359 (34%) 131 (12%)
aReference date is the date of diagnosis for cases and the date of
telephone screening call for controls.
Table II Numbers (and percentages) of women using cancer screening methods by stage at diagnosis in the 5 year period prior to
1 year before reference datea
Stage of tumour
Method of - In situ Local Regional/distant Controls P-valuefor
examination used (n =228) (n = 784) (n =604) (n = 1505) heterogeneity"
Mammogram n (%) 151 (66%) 427 (54%) 284 (47%) 687 (46%) P<0.001
Number of mammograms
None n (%) 77 (34%) 356 (45%) 318 (53%) 815 (54%)
1 55 (24%) 172 (22%) 135 (22%) 380 (25%)
2 35 (15%) 117 (15%) 63 (10%) 156 (10%)
3 + 61 (27%) 138 (18%) 86 (14%) 151 (10%)
Breast self-examination n (%) 166 (73%) 604 (77%) 473 (78%) 1158 (77%) P=0.45
Breast examination by doctor n (%) 168 (74%) 534 (68%) 369 (61%) 912 (61%) P<0.001
Pap smear n (%) 224 (98%) 745 (95%) 570 (94%) 1400 (93%) P=0.01
aReference date is the date ofdiagnosis forcases, and the date oftelephone screeningcall forcontrols. bCalculated using thechi-square test for a
difference in proportions (Fleiss, 1973).In situ and invasive breast cancer
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Relative risks associated with menstrual and reproductive
factors are shown in Table V. There was some evidence of an
increased risk of local tumours among women with an early
age at menarche, but this was not apparent for either in situ
or regional/distant tumours. Nulliparous women were at a
significantly increased risk of in situ (RR = 2.10) and local
(RR= 1.65) tumours compared with parous women, and to a
lesser extent of regional/distant tumours (RR = 1.21). A test
of heterogeneity showed some evidence of a difference in
relative risk associated with parity for in situ tumours
compared with regional/distant tumours (P = 0.05), but no
significant difference between the risks for in situ and local
(P=0.36), or local and regional/distant tumours (P=0.11).
Among parous women, there was a borderline significant
decreasing trend in RR with increasing parity for both in situ
and local tumours. In both groups, women with four or more
full-term births were at almost half the risk of women with
one full term birth. In contrast, there was no clear effect of
increasing parity on the risk of regional/distant tumours.
For regional/distant tumours there was a significant
increasing risk with older age at first full-term birth
(RR>30= 1.69; P-value for trend=0.02). There was less
evidence of a rising risk with increasing age at first birth
for local tumours (RR>,30= 1.37; P-value for trend=0.16),
and for in situ tumours (RR>30= 1.34; P-value for
trend =0.13). There was no evidence of heterogeneity
Table IV Relative risks of breast cancer for family history, breast biopsy and race, by stage at diagnosis
In situ Local Regional/distant
Riskfactor Cases RR 95% CI Cases RR 95% CI Cases RR 95% CI
First-degree relative with breast cancera
None 187 1.00 670 1.00 515 1.00
At least one first- 39 2.48 1.6-3.8 109 2.20 1.6-3.0 81 2.41 1.7-3.3
degree relative
Mother only 33 2.52 1.6-4.0 90 2.18 1.6-3.0 69 2.48 1.7-3.5
One or more sister only 3 1.37 0.4-5.0 16 2.25 1.1-4.8 10 2.01 0.9-4.6
Both 3 6.93 1.1 -44 3 2.66 0.4- 1 7 2 2.68 0.4- 1 9
Previous breast biopsya
No 192 1.00 713 1.00 553 1.00
Yes 36 1.99 1.2-3.0 71 1.23 0.9- 1.7 51 1.28 0.9- 1.9
Racea
White 186 1.00 628 1.00 465 1.00
African-American 33 1.84 1.2-2.9 107 1.25 0.9- 1.7 109 1.38 1.0- 1.8
Other 9 0.66 0.3-1.4 49 1.12 0.8- 1.6 30 0.87 0.6-1.3
a Relative risks adjusted for age at diagnosis, study site, a combination variable including number offull-term births and age at first full-term
birth, age at menarche, years of oral contraception use, body mass index, number ofmammograms in the 5 years prior to 1 year before reference
date, and all other variables in this table.
Table V Relative risks of breast cancer for menstrual and reproductive factors by stage at diagnosis
In situ Local Regional/distant
Riskfactor Cases RR 95% CI Cases RR 95% CI Cases RR 95% CI
Age at menarche (years)a
,14 43 1.00 120 1.00 123 1.00
13 68 1.04 0.7- 1.6 223 1.27 1.0- 1.7 145 0.78 0.6- 1.0
12 70 1.19 0.8- 1.8 259 1.65 1.3-2.2 172 1.03 0.8- 1.4
< I1 46 0.97 0.6- 1.5 182 1.44 1.1 -1.9 163 1.15 0.9- 1.5
Parousb
Yes 155 1.00 576 1.00 483 1.00
No 73 2.10 1.3-3.5 208 1.65 1.2-2.2 121 1.21 0.9- 1.7
Number of full-term birthsc
1 45 1.00 170 1.00 116 1.00
2 76 1.07 0.7- 1.7 268 0.92 0.7- 1.2 239 1.34 1.0- 1.8
3 25 0.77 0.4-1.4 103 0.79 0.6-1.1 90 1.08 0.7- 1.6
)4 9 0.55 0.2- 1.3 35 0.54 0.3 -0.9 38 0.88 0.5- 1.5
Age at first full-term birth (years)c
<20 28 1.00 100 1.00 87 1.00
20-24 39 0.84 0.4- 1.8 183 1.22 0.9-1.7 143 1.16 0.8- 1.6
25-29 48 1.11 0.6-2.0 172 1.28 0.9-1.8 131 1.16 0.8-1.7
>30 39 1.34 0.6-2.9 121 1.37 0.9-2.2 122 1.69 1.0-2.7
Interval since last birth (years)c
< 5 37 1.00 138 1.00 161 1.00
5-9 38 0.99 0.6-1.7 155 1.19 0.9- 1.6 137 0.98 0.7- 1.3
10- 15 49 1.30 0.7-2.4 147 1.25 0.9- 1.8 89 0.74 0.5- 1.1
> 15 29 0.84 0.4- 1.8 134 1.19 0.8- 1.9 94 0.83 0.5- 1.3
aRelative risks adjusted for age at diagnosis, study site, race, family history, previous breast biopsy, a combination variable including number of
full-term births and age at first full-term birth, years oforalcontraception use, bodymass index and number ofmammograms in the 5 years prior to
1 year before referencedate. bRelative risks adjusted forageatdiagnosis, study site, race, familyhistory, previous breastbiopsy, ageatfirstfull-term
birth, years oforal contraception use, body mass index and number ofmammograms in the 5 years prior to 1 year before reference date. cAmong
parous women only. Relative risks adjusted for age at diagnosis, study site, race, family history, previous breast biopsy, years oforal contraception
use, body mass index, number ofmammograms in the 5 years prior to 1 yearbeforereference date, and the otherreproductivevariables in this table.In situ and invasive breast cancer
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between the trends for any two stages. No variation in RR
was seen for any stage at diagnosis with time since last full-
term birth, years of breast feeding among women with live
births, or with miscarriages or induced abortions among ever
pregnant women (data not shown).
Table VI shows relative risk for alcohol consumption,
body mass index (BMI) and level of education. As these
variables are associated with each other, the RRs for each
exposure was adjusted for the other two, as well as for other
established or suspected breast cancer risk factors, including
cigarette smoking. Detailed analyses of breast cancer risk
associated with smoking in this data are in progress and will
be reported separately.
Frequent alcohol consumption was associated with an
increased risk of local and regional/distant tumours. For
regional/distant tumours, there was a significant increased
risk associated with an average consumption of 14 or more
drinks per week (RR =2.52). For local tumours, the
magnitude of RR at each consumption level was lower than
for regional/distant tumours, and the RR among women
drinking 14 or more drinks a week was 1.62 (P-value for
heterogeneity with regional/distant tumours =0.09). The
number of frequent drinkers among women diagnosed with
in situ tumours was small, but there was no suggestion of an
increased risk among drinkers. The risk of in situ tumours
associated with frequent drinking was significantly less than
of regional/distant tumours (P=0.01).
There was a highly significant decrease in RR with
increasing BMI for in situ tumours (P-value for
trend=0.002), with heavy women at half the risk of lean
women (RR =0.45). There was also a decreasing risk of local
tumours with increasing BMI (P<0.001), but in contrast,
there was no effect of BMI on regional/distant tumours. The
trends of RR with increasing BMI differed significantly
between regional/distant and in situ tumours (P<0.01), and
between regional/distant and local tumours (P=0.03). In
contrast, there was no evidence of a difference in trend ofrisk
between local and in situ tumours (P=0.12).
Education above high school level was associated with a
decreased risk of in situ tumours though the trend in RR with
increasing education level was not statistically significant
(P=0.09). There was no variation in RR for local or
regional/distant tumours.
Table VII shows risk factors of in situ tumours by
histological type. Histology data were available for 224 of
the 228 in situ tumours, of which 156 (70%) were ductal
carcinoma in situ (DCIS) and 43 (19%) were lobular
carcinoma in situ (LCIS). Of the remaining cases, 13 were
diagnosed with both DCIS and LCIS, nine with cribriform
carcinoma in situ, two with intraepithelial carcinoma in situ,
one with Paget's disease of the nipple, and histology was
unknown for four cases. The mean age at diagnosis for
women diagnosed with LCIS (40.5 years) was slightly higher
than for women with DCIS (39.3 years). DCIS and LCIS
were both associated with most established breast cancer risk
factors. The magnitude of association was greater for DCIS
than for LCIS for a positive family history of breast cancer,
nulliparity, number of full-term births and body mass index,
although numbers of cases of LCIS were small and
confidence intervals correspondingly wide. In contrast, LCIS
was more closely associated with a previous breast biopsy
(RR= 3.80) than DCIS (RR= 1.86).
Discussion
The recent increase in the incidence of breast carcinoma in
situ has focused interest on the relationship between in situ
and invasive breast carcinoma. There is increasing evidence
that in situ breast cancer is a precursor of invasive disease
(Holzman, 1995) and hence the study of risk factors
associated with carcinoma in situ may also clarify the
aetiology of invasive breast cancer.
Few studies have examined risk factors associated with
early stage breast cancer, and this study supports these
(Brinton et al., 1983; Claus et al., 1993) in showing that risk
factors for in situ tumours are broadly similar to those for
local and regional/distant tumours. In addition, this is the
only study to focus on the epidemiology of in situ tumours
among young women. The BCDDP study (Brinton et al.,
1983) suggested that risk factors operating relatively early in
life (such as family history) could be involved in the initial
stages of carcinogenesis, resulting in carcinoma in situ, with
other factors needed to continue promoting the tumour to
invasion. A limitation of the BCDDP study is that complete
screening information was not available, and hence the effect
of screening bias could not be fully evaluated.
The strengths of the present study include the population-
based sample of cases and controls, and the data on screening
history. Screening of asymptomatic patients is used to detect
early-stage breast cancer, and this study confirms that women
diagnosed with in situ tumours were more likely to have
undergone routine mammograms than women diagnosed
with local or regional/distant tumours. RRs were thus
Table VI Relative risks of breast cancer for alcohol consumption, body mass index and education by stage at diagnosis
In situ Local Regional/distant
Riskfactor Cases RRa 95% CI Cases RRa 95% CI Cases RRa 95% CI
Alcohol use (average drinks per week)b
Non drinker 78 1.00 275 1.00 204 1.00
<1 -6.9 125 1.01 0.7-1.4 400 0.97 0.8- 1.2 308 1.15 0.9-1.4
7- 13.9 20 0.99 0.6- 1.8 69 1.11 0.8-1.6 49 1.21 0.8- 1.8
> 14 5 0.65 0.2- 1.8 40 1.62 1.0-2.6 41 2.52 1.6-4.1
Body mass index (kg m-2)
<22 81 1.00 242 1.00 152 1.00
22-24.59 53 0.64 0.4-0.9 191 0.77 0.6- 1.0 129 0.81 0.6-1.1
24.6-29.02 49 0.63 0.4-0.9 179 0.75 0.6- 1.0 162 1.06 0.8- 1.4
29.03 39 0.45 0.3-0.7 162 0.65 0.5-0.8 145 0.88 0.7-1.2
Years of education
High school or less 64 1.00 197 1.00 161 1.00
Technical school 16 0.73 0.4-1.3 54 0.89 0.6-1.3 40 0.82 0.5-1.2
Some college 50 0.54 0.4-0.8 206 0.93 0.7-1.1 169 0.97 0.7-1.3
College graduate 60 0.64 0.4-1.0 205 0.97 0.8-1.3 141 0.90 0.7-1.2
Post graduate 38 0.67 0.4-1.1 122 0.98 0.7-1.3 93 1.06 0.8-1.5
aRelative risks adjusted for age at diagnosis, study site, race, family history, previous breast biopsy, number offull-term births, age at first full-
term birth, age at menarche, years oforal contraception use, number ofmammograms in the 5 years prior to 1 year before reference date, smoking
habits, and all other variables in this table. bLifetime average number ofdrinks consumed per week, up to 2 years before diagnosis or telephone
screener.In situ and invasive breast cancer
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Table VII Distribution of risk factors by histological type of in situ tumour
Ductal carcinoma in situ Lobular carcinoma in situ Othera
(n=156) b (n=43) b (n -29) b Riskfactor n RR n RR n RRb
First-degree relative with breast cancer
None 130 1.0 37 1.0 20 1.0
At least one 25 2.50 (1.5-4.2) 5 1.61 (0.6-4.4) 9 6.56 (2.7-16)
Previous breast biopsy
No 134 1.0 33 1.0 25 1.0
Yes 22 1.86 (1.1 -3.2) 10 3.80 (1.7-8.6) 4 1.69 (0.5-5.5)
Race
White 127 1.0 34 1.0 25 1.0
African-American 22 1.65 (1.0-2.9) 7 1.99 (0.7-5.3) 4 1.56 (0.2- 1.8)
Other 7 0.71 (0.3- 1.6) 2 0.98 (0.2-4.5) - -
Parousc
Yes 105 1.0 31 1.0 19 1.0
No 51 2.31 (1.3-4.2) 12 1.89 (0.7-5.5) 10 1.93 (0.6-6.2)
Number of full-term births
1 35 1.00 6 1.00 4 1.00
2 48 0.80 (0.5- 1.3) 18 2.37 (0.9-6.6) 10 1.25 (0.4-4.3)
3 16 0.54 (0.3-1.0) 5 1.24 (0.3-4.7) 4 0.86 (0.2-3.9)
,_4 6 0.47 (0.2- 1.2) 2 1.00 (0.2-5.8) 1 0.45 (0.1-4.6)
Age at first full-term birthd
<20 18 1.00 6 1.00 4 1.00
20-24 28 0.89 (0.5- 1.7) 6 0.32 (0.1-1.2) 5 0.60 (0.2-2.2)
25-29 32 1.11 (0.6-2.2) 10 0.99 (0.3-3.2) 6 0.66 (0.2-2.5)
,30 27 1.23 (0.6-2.5) 9 1.37 (0.4-4.8) 3 0.48 (0.1-2.4)
Body mass index (kg m-2)
<22 61 1.00 12 1.00 8 1.00
22-24.59 33 0.55 (0.4-0.9) 11 0.99 (0.4-2.3) 8 1.31 (0.5-3.6)
24.6-29.02 33 0.57 (0.4-0.9) 8 0.71 (0.3- 1.8) 7 1.22 (0.4-3.5)
>29.03 25 0.41 (0.2-0.7) 10 0.92 (0.4-2.3) 5 0.52 (0.1 -1.9)
a Includes 13 women diagnosed with both intraductal carcinoma and lobular carcinoma in situ, nine with cribriform carcinoma in situ, two with
intraepithelial carcinoma in situ, one with Paget's disease of the nipple and four with unknown histology. b Relative risks adjusted for age at
diagnosis study, site, smoking, number ofmammograms in the 5 years prior to 1 year before reference date, and all other risk factors in this table.
cRelative risks adjusted for age at diagnosis, site, smoking, number ofmammograms in the 5 years prior to 1 year before reference date, and all other
risk factors in this table except number of full-term births. d Among parous women only.
adjusted for the number of mammograms in the 5 year
period prior to 1 year before reference date, but further
adjustment for other screening methods (i.e. physical breast
examination or BSE) did not alter the RRs, owing to the
correlation between use of different screening methods. Local
and regional/distant tumours were most likely to be detected
by the patient or her partner (through BSE or accidental
discovery), and our results are similar to those of a recent
study of breast cancer patients in Wisconsin, where 22% of
invasive tumours in premenopausal women were detected by
routine mammograms and 72% by BSE or accidental
discovery (Reeves et al., 1995). A possible source of residual
confounding arises from differing methods used to detect the
tumours. To assess this potential confounding in the present
study, further analyses were carried out using case data only
(Begg and Zhang, 1994). Relative risks for models including a
risk factor, screening history and other confounders were
calculated for local and regional/distant tumours relative to
in situ tumours. The addition of detection method in the
model had little effect on the odds rations, giving no evidence
of residual confounding by method of detection.
A history of breast cancer in a first-degree relative is an
established risk factor, especially among younger women
(Eby et al., 1994), and in this study a greater than 2-fold risk
was seen for each stage of diagnosis. The risks in the BCDDP
study were slightly lower (RR= 1.5, Brinton et al., 1983),
possibly because the controls in that study had volunteered to
be screened and may have had a higher prevalence of a
family history of breast cancer than the general population.
Previous studies have shown a greater risk of in situ
compared with invasive tumours among patients with
previous breast biopsies or benign breast disease (Brinton et
al., 1983; Dubin et al., 1984; Claus et al., 1993), possibly as a
result of early detection through frequent screening. In the
present study, the magnitude and significance of the increased
risk associated with a breast biopsy was greater for in situ
tumours than for local or regional/distant tumours, even after
adjusting for number of mammograms. Benign breast disease
is an established risk factor for invasive breast cancer, and
women with atypical hyperplasia are at a particularly high
risk (Bodian, 1993; Ma and Boyd, 1992). The greater
association of biopsy with in situ tumours than with local
or regional/distant tumours supports the close relationship
between benign tumours, carcinoma in situ and invasive
carcinoma (Bodian, 1993). It is also possible that the lack of
a clear demarcation between atypical hyperplasia and in situ
tumours may result in diagnostic misclassification, leading to
the observed association (Bodian, 1993; Marcus et al., 1994).
An increased breast cancer risk among young African-
American women compared with white women remains
largely unexplained (Kelsey and Horn Ross, 1993), and in
this study the increase persisted after adjusting for possible
confounders. The increased risk for in situ disease among
African-Americans was also found in a case-control study
of a screened population of women aged over 35, but, in
contrast, no increase was seen for invasive disease (Dubin et
al., 1984).
Early age at menarche is an established risk factor for
breast cancer (Kelsey et al., 1993). There was some evidence
of an increased risk with earlier age at menarche for local
tumours, but no association with carcinoma in situ. The
BCDDP study also found no association with in situ tumours
or small tumours, but there was a significant increasing trend
with younger age at menarche for tumours greater than 1 cm
(Brinton et al., 1983).
Nulliparity is also an established breast cancer risk factor,
though the increased risk is not so apparent among women
aged less than 40 (Janerich and Hoff, 1982; Kelsey et al.,In situ and invasive breast cancer
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1993; Velentgas and Daling, 1994). The present study shows
variation in the effect of parity by stage of disease.
Nulliparous women were at a significantly increased risk of
in situ and local tumours. Women with four or more full-
term births were at about half the risk of women with a
single birth, for both in situ and local disease. This reduction
in risk has not been seen previously (Dubin et al., 1984). In
contrast, no clear effect of parity was seen for regional/
distant tumours. One possible explanation for this difference
is that if pregnancy causes a short-term increase in breast
cancer risk followed by a long-term protection effect (Kelsey
et al., 1993), parous women aged less than 45 may have
protection from early-stage tumours, but not from later stage
tumours. However, one would then expect a decreasing trend
in RR of in situ tumours with increasing time since last birth,
and this was not apparent. Late age at first birth is a breast
cancer risk factor, especially among younger women
(Velentgas and Daling, 1994), and was significantly
associated with regional/distant tumours and to a lesser
extent, in situ and local tumours. The BCDDP study (Brinton
et al., 1983) showed a significant increase in risk of all stages
of disease with increasing age at first birth, but another study
showed no relationship between in situ tumours and age at
first birth (Dubin et al., 1984).
Consumption of a lifetime average of two or more
alcoholic drinks per day was associated with a significantly
increased risk of regional/distant tumours in this study. To
our knowledge, the relationship between stage of breast
cancer and alcohol consumption has not previously been
examined, but other studies have found overall associations
with alcohol consumption (Rosenberg et al., 1993). The
association has been seen in both cohort and case-control
studies, and persists after adjustment for known confounding
factors. If alcohol consumption is indeed a causal factor of
breast cancer, it would be one of few readily modifiable risk
factors known (the others being physical exercise in younger
women and weight loss in older women; Brinton, 1994).
However, no definite biological explanation for the associa-
tion is known. There are several possible mechanisms
including the stimulation of prolactin secretion, decreased
clearance of oestrogen by the liver (Velentgas and Daling,
1994), or possibly an alcohol-induced increase in total
oestrogen levels (Reichman et al., 1993), and further research
is needed in this area. The lack of a significant increased risk
for in situ tumours found in the present study may be due to
small numbers, or may indicate that alcohol affects the
progression of tumours from in situ to invasive. Detailed
analyses of alcohol intake in this study are currently
underway.
Some studies have shown an inverse association between
body mass index and breast cancer risk in premenopausal
women (Hunter and Willet, 1993), and the relationship in the
present study has been analysed previously (Swanson et al.,
1996). Small tumours are more difficult to detect in obese
women, but the reduced risk of in situ and local tumours
associated with increased BMI is unlikely to be due to
detection bias since the inverse relationship held among
women whose tumours were found by mammography, a
detection method unlikely to be affected by BMI (Swanson et
al., 1996).
A previously published analysis ofthis data (Brinton et al.,
1995) has examined the RRs of different stages of breast
cancer associated with use of oral contraceptives, and found
that use for at least 6 months was associated with both local
and regional/distant tumours, but not in situ tumours. This
supports evidence from other studies (Kay and Hannaford,
1988; Romieu et al., 1989; Olsson et al., 1991) that oral
contraceptives can induce cell proliferation or other late-stage
events.
This study is one of the largest to examine risk factors by
histological type of early-stage breast cancer and our results
support the theory that ductal carcinoma in situ is more
closely related to invasive breast cancer than the lobular
form. Results from studies of risk factors by histological
types of in situ breast cancer have been inconsistent (Marcus
et al., 1994). The association between family history and
DCIS has been suggested previously (Erdreich et al., 1980)
but the present study is the first to show a significantly
increased risk. Several previous studies (Rosen et al., 1982;
Claus et al., 1993) have suggested that LCIS is related to
family history. The 4-fold risk of LCIS following a previous
breast biopsy is not unexpected, as LCIS is usually detected
as a result of a biopsy given for some other reason (Bodian,
1993).
To conclude, this study provides epidemiological support
for the theory that in situ, local and regional/distant breast
cancer are closely related. Increased risks of similar
magnitude for all stages of disease were associated with a
family history of breast cancer. For some risk factors,
including a previous breast biopsy, parity, African-Amer-
ican race and body mass index, the magnitude of association
was greater for in situ disease than for local or regional/
distant disease and this persisted after adjustment for number
of mammograms, indicating that it was not due to screening
bias. This tends to suggest that in situ tumours are likely to
be on the causal pathway of invasive tumours. The significant
association between alcohol consumption and invasive
tumours, but not in situ tumours, indicates that alcohol
may be involved in late-stage events. Analyses by histological
type of in situ tumours suggested that both ductal and
lobular carcinoma in situ were associated with most
established breast cancer risk factors, and the magnitude of
association tended to be greater for the ductal form.
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